LATANOPROST

LATANOPROST was reported 50806 times

LATANOPROST is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EYELASH THICKENING 29 0.2417
1 INTRAOCULAR PRESSURE FLUCTUATION 43 0.2183
2 INTRAOCULAR PRESSURE TEST ABNORMAL 127 0.1801
3 IRIS HYPERPIGMENTATION 37 0.1779
4 PRODUCT CLOSURE REMOVAL DIFFICULT 181 0.1775
5 GLAUCOMA SURGERY 45 0.1758
6 STEROID DEPENDENCE 148 0.1686
7 CATARRH 147 0.1626
8 GROWTH OF EYELASHES 115 0.1452
9 INTRAOCULAR PRESSURE INCREASED 1796 0.1404
10 PRODUCT DROPPER ISSUE 94 0.1194
11 OCULAR SURFACE DISEASE 30 0.1068
12 INTRAOCULAR PRESSURE DECREASED 54 0.1025
13 REACTION TO PRESERVATIVES 75 0.0921
14 BURNS SECOND DEGREE 157 0.0894
15 HYPOTONY OF EYE 37 0.0881
16 OPEN ANGLE GLAUCOMA 51 0.0831
17 CHOROIDAL DETACHMENT 42 0.0757
18 EYE LASER SURGERY 43 0.0728
19 TREATMENT FAILURE 5934 0.0716
20 GLAUCOMA 1372 0.0712
21 BLEPHARAL PIGMENTATION 30 0.0594
22 HYPHAEMA 31 0.0594
23 EYE BURNS 32 0.0543
24 FOREIGN BODY SENSATION IN EYES 340 0.0533
25 CHOROIDAL EFFUSION 41 0.0511
26 EYE COLOUR CHANGE 51 0.0501
27 INSTILLATION SITE ERYTHEMA 26 0.0492
28 HYPOPNOEA 161 0.0463
29 CORNEAL DISORDER 99 0.0451
30 CORNEAL OPACITY 60 0.0439
31 DARK CIRCLES UNDER EYES 59 0.0401
32 EPIDERMAL NECROSIS 39 0.0400
33 EYE IRRITATION 2305 0.0400
34 CORNEAL DEPOSITS 29 0.0390
35 ALCOHOL POISONING 104 0.0388
36 CORNEAL OEDEMA 84 0.0374
37 EYE ALLERGY 58 0.0374
38 OCULAR VASCULAR DISORDER 29 0.0352
39 PRODUCT DESIGN ISSUE 25 0.0350
40 EYELID DISORDER 80 0.0347
41 OCULAR HYPERTENSION 67 0.0345
42 PUNCTATE KERATITIS 31 0.0338
43 DENTAL RESTORATION FAILURE 24 0.0333
44 PERIORBITAL PAIN 28 0.0331
45 PRODUCT CONTAINER ISSUE 281 0.0327
46 CATARACT OPERATION 192 0.0323
47 EYELID IRRITATION 80 0.0319
48 PRODUCT PACKAGE ASSOCIATED INJURY 71 0.0318
49 INSTILLATION SITE IRRITATION 37 0.0312
50 CYSTOID MACULAR OEDEMA 58 0.0308
51 EYELID PAIN 62 0.0305
52 PRODUCT CONTAINER SEAL ISSUE 53 0.0304
53 EYE PAIN 1689 0.0299
54 EYELID MARGIN CRUSTING 86 0.0297
55 SUPERFICIAL INJURY OF EYE 32 0.0293
56 FOREIGN BODY IN EYE 28 0.0292
57 CONJUNCTIVAL HYPERAEMIA 103 0.0289
58 BRONCHIECTASIS 193 0.0286
59 OCULAR HYPERAEMIA 1348 0.0284
60 OPTIC NERVE DISORDER 45 0.0281
61 INSTILLATION SITE PAIN 69 0.0278
62 COLITIS MICROSCOPIC 131 0.0276
63 ERYTHEMA OF EYELID 146 0.0269
64 MACULAR HOLE 36 0.0268
65 OPTIC NERVE INJURY 30 0.0258
66 BLEPHARITIS 100 0.0249
67 CORNEAL ABRASION 33 0.0241
68 PAROSMIA 177 0.0234
69 RHINITIS 188 0.0233
70 CATARACT 1388 0.0233
71 ABNORMAL SENSATION IN EYE 100 0.0232
72 OCULAR DISCOMFORT 260 0.0231
73 CONJUNCTIVITIS ALLERGIC 34 0.0229
74 GINGIVAL PAIN 179 0.0225
75 EYE PRURITUS 739 0.0220
76 ANGLE CLOSURE GLAUCOMA 56 0.0219
77 VISUAL ACUITY REDUCED 718 0.0216
78 EYELIDS PRURITUS 67 0.0215
79 CARDIAC MURMUR 182 0.0210
80 EYE DISCHARGE 217 0.0209
81 EYE OEDEMA 51 0.0208
82 VISUAL FIELD DEFECT 147 0.0203
83 EYE DISORDER 661 0.0201
84 BLINDNESS UNILATERAL 282 0.0200
85 ESSENTIAL HYPERTENSION 36 0.0197
86 NASAL DISCHARGE DISCOLOURATION 26 0.0188
87 ANGIOPLASTY 28 0.0188
88 EYE OPERATION 86 0.0186
89 PRODUCT DELIVERY MECHANISM ISSUE 98 0.0182
90 IRIDOCYCLITIS 57 0.0180
91 INCORRECT STORAGE OF DRUG 31 0.0179
92 ULCERATIVE KERATITIS 49 0.0179
93 PRODUCT PACKAGING DIFFICULT TO OPEN 45 0.0172
94 HYPERPARATHYROIDISM SECONDARY 43 0.0171
95 ASTHENOPIA 90 0.0164
96 METAMORPHOPSIA 30 0.0163
97 EYE INJURY 49 0.0161
98 RETINAL DISORDER 40 0.0154
99 OPHTHALMOPLEGIA 24 0.0152
100 EYE INFLAMMATION 145 0.0152
101 KERATITIS 45 0.0148
102 LACRIMATION INCREASED 446 0.0147
103 NEPHROGENIC ANAEMIA 67 0.0144
104 VITREOUS HAEMORRHAGE 39 0.0141
105 DRY EYE 702 0.0140
106 PHOTOPHOBIA 263 0.0140
107 RETINAL TEAR 33 0.0134
108 MACULAR DEGENERATION 158 0.0132
109 MACULAR OEDEMA 74 0.0132
110 IRITIS 40 0.0131
111 EYE INFECTION 144 0.0127
112 VITREOUS DETACHMENT 27 0.0124
113 EXPIRED DRUG ADMINISTERED 60 0.0121
114 IMPAIRED QUALITY OF LIFE 169 0.0117
115 EYELID OEDEMA 135 0.0116
116 BLINDNESS 472 0.0116
117 BODY HEIGHT DECREASED 123 0.0115
118 MYOPIA 27 0.0113
119 HEARING IMPAIRED 68 0.0113
120 RETINAL DETACHMENT 104 0.0113
121 VISION BLURRED 1542 0.0112
122 PERIPHERAL VASCULAR DISORDER 56 0.0109
123 TUBULOINTERSTITIAL NEPHRITIS 202 0.0108
124 MACULOPATHY 37 0.0104
125 LABYRINTHITIS 26 0.0103
126 EYE HAEMORRHAGE 137 0.0103
127 EYE SWELLING 378 0.0102
128 MENISCUS INJURY 62 0.0101
129 PERIORBITAL SWELLING 57 0.0101
130 VITREOUS FLOATERS 99 0.0101
131 SWELLING OF EYELID 63 0.0100
132 EPIGASTRIC DISCOMFORT 39 0.0100
133 CREPITATIONS 29 0.0097
134 THYROID DISORDER 150 0.0097
135 TOXIC EPIDERMAL NECROLYSIS 145 0.0095
136 PRODUCT USE COMPLAINT 149 0.0094
137 ATRIAL FLUTTER 75 0.0094
138 RETINAL VEIN OCCLUSION 27 0.0094
139 BLINDNESS TRANSIENT 64 0.0087
140 POOR QUALITY PRODUCT ADMINISTERED 90 0.0085
141 PRODUCT FORMULATION ISSUE 56 0.0085
142 PHOTOPSIA 53 0.0084
143 CONJUNCTIVAL HAEMORRHAGE 32 0.0084
144 PRODUCT PACKAGING ISSUE 79 0.0083
145 VISUAL IMPAIRMENT 1030 0.0083
146 EAR DISORDER 38 0.0083
147 HEART RATE ABNORMAL 46 0.0082
148 VISUAL DISTURBANCE 47 0.0082
149 BLOOD MAGNESIUM DECREASED 69 0.0080
150 SKIN REACTION 112 0.0079
151 FREQUENT BOWEL MOVEMENTS 214 0.0079
152 SWOLLEN TONGUE 247 0.0079
153 DEAFNESS NEUROSENSORY 26 0.0079
154 POOR QUALITY DRUG ADMINISTERED 51 0.0079
155 PHLEBITIS 40 0.0078
156 HAEMORRHAGIC ANAEMIA 34 0.0077
157 DIVERTICULITIS 208 0.0075
158 PIGMENTATION DISORDER 46 0.0074
159 SYNOVITIS 134 0.0074
160 IMPAIRED WORK ABILITY 157 0.0073
161 CONJUNCTIVITIS 136 0.0073
162 TINNITUS 331 0.0072
163 UVEITIS 96 0.0071
164 DIABETIC RETINOPATHY 24 0.0071
165 RENAL CYST 56 0.0070
166 ATRIOVENTRICULAR BLOCK COMPLETE 47 0.0070
167 EYELID PTOSIS 71 0.0070
168 HOSPICE CARE 69 0.0070
169 RED CELL DISTRIBUTION WIDTH INCREASED 29 0.0070
170 MADAROSIS 80 0.0069
171 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 28 0.0069
172 NIGHTMARE 236 0.0068
173 INCREASED UPPER AIRWAY SECRETION 35 0.0068
174 BENIGN PROSTATIC HYPERPLASIA 35 0.0068
175 PERIPHERAL VENOUS DISEASE 27 0.0066
176 RETINAL HAEMORRHAGE 46 0.0065
177 DIVERTICULUM INTESTINAL 28 0.0064
178 HYPERSENSITIVITY 1181 0.0064
179 ENCEPHALITIS 44 0.0064
180 SEASONAL ALLERGY 90 0.0064
181 LARGE INTESTINE POLYP 44 0.0063
182 END STAGE RENAL DISEASE 115 0.0063
183 BLOOD CHOLESTEROL ABNORMAL 29 0.0063
184 DIPLOPIA 163 0.0063
185 LIMB INJURY 169 0.0062
186 VERTIGO 378 0.0062
187 IRON DEFICIENCY ANAEMIA 57 0.0062
188 RECTAL HAEMORRHAGE 265 0.0062
189 ARTHRITIS 485 0.0062
190 PROSTATOMEGALY 24 0.0061
191 DIABETIC NEUROPATHY 30 0.0061
192 ACCIDENTAL OVERDOSE 221 0.0060
193 LIQUID PRODUCT PHYSICAL ISSUE 44 0.0060
194 HORDEOLUM 26 0.0060
195 ORTHOSTATIC HYPOTENSION 104 0.0060
196 PERIORBITAL OEDEMA 31 0.0060
197 EMPHYSEMA 60 0.0059
198 UPPER GASTROINTESTINAL HAEMORRHAGE 99 0.0059
199 HYPOACUSIS 252 0.0058
200 RHINITIS ALLERGIC 26 0.0058
201 SINUS DISORDER 115 0.0058
202 HAIR GROWTH ABNORMAL 40 0.0058
203 DYSLIPIDAEMIA 29 0.0057
204 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 44 0.0057
205 SKIN LACERATION 61 0.0056
206 RENAL FAILURE CHRONIC 43 0.0056
207 INFARCTION 38 0.0055
208 LOWER GASTROINTESTINAL HAEMORRHAGE 41 0.0055
209 ANGIOPATHY 31 0.0055
210 SKIN ABRASION 26 0.0055
211 DYSPNOEA EXERTIONAL 207 0.0055
212 HYPERAESTHESIA 45 0.0055
213 C-REACTIVE PROTEIN ABNORMAL 35 0.0055
214 HYPERKERATOSIS 30 0.0054
215 FULL BLOOD COUNT ABNORMAL 57 0.0054
216 VITAMIN D DECREASED 46 0.0054
217 PRODUCT RESIDUE PRESENT 29 0.0054
218 RESPIRATORY TRACT CONGESTION 85 0.0053
219 BRONCHITIS 396 0.0053
220 DIVERTICULUM 38 0.0053
221 ENDOPHTHALMITIS 32 0.0053
222 INTERVERTEBRAL DISC DEGENERATION 49 0.0053
223 PRODUCT ADMINISTRATION ERROR 107 0.0053
224 BLOOD PRESSURE ABNORMAL 105 0.0053
225 ABDOMINAL HERNIA 24 0.0053
226 HIATUS HERNIA 68 0.0052
227 CARDIAC PACEMAKER INSERTION 31 0.0052
228 ARRHYTHMIA 246 0.0052
229 NASAL DISCOMFORT 41 0.0052
230 WHITE BLOOD CELL COUNT ABNORMAL 33 0.0052
231 BLOOD PRESSURE FLUCTUATION 124 0.0052
232 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 248 0.0052
233 HALLUCINATION, VISUAL 109 0.0052
234 FACIAL PARALYSIS 44 0.0052
235 GROIN PAIN 45 0.0051
236 INCORRECT PRODUCT STORAGE 67 0.0051
237 DYSGEUSIA 377 0.0051
238 OBSTRUCTIVE AIRWAYS DISORDER 56 0.0050
239 TRANSIENT ISCHAEMIC ATTACK 169 0.0050
240 UPPER-AIRWAY COUGH SYNDROME 41 0.0050
241 HAEMOGLOBIN ABNORMAL 32 0.0050
242 SPUTUM DISCOLOURED 47 0.0050
243 OSTEOARTHRITIS 210 0.0049
244 NASAL DRYNESS 31 0.0049
245 PROSTATIC SPECIFIC ANTIGEN INCREASED 68 0.0049
246 FAECALOMA 27 0.0049
247 GOUT 88 0.0049
248 HYPONATRAEMIA 276 0.0049
249 DEAFNESS UNILATERAL 27 0.0049
250 CARDIAC VALVE DISEASE 28 0.0049
251 PROSTATIC DISORDER 27 0.0049
252 EXTRASYSTOLES 34 0.0049
253 HEART RATE IRREGULAR 110 0.0049
254 HYPERLIPIDAEMIA 58 0.0048
255 COMPRESSION FRACTURE 26 0.0048
256 HYPERKALAEMIA 170 0.0048
257 ARTERIAL OCCLUSIVE DISEASE 38 0.0048
258 SCIATICA 77 0.0048
259 SYSTEMIC LUPUS ERYTHEMATOSUS 171 0.0048
260 ONYCHOCLASIS 33 0.0048
261 DRUG INTOLERANCE 463 0.0048
262 HAEMATOCRIT DECREASED 95 0.0048
263 PULMONARY CONGESTION 63 0.0048
264 ATRIAL FIBRILLATION 465 0.0048
265 INFUSION SITE SWELLING 30 0.0048
266 INTERNATIONAL NORMALISED RATIO INCREASED 135 0.0047
267 CORONARY ARTERY DISEASE 143 0.0047
268 BLOOD SODIUM DECREASED 89 0.0047
269 DYSGRAPHIA 31 0.0047
270 DELUSION 73 0.0047
271 MEDICATION ERROR 261 0.0047
272 SUBDURAL HAEMATOMA 67 0.0047
273 UROSEPSIS 43 0.0047
274 SINUS BRADYCARDIA 45 0.0047
275 SPINAL DISORDER 44 0.0046
276 BEDRIDDEN 61 0.0046
277 DEAFNESS 121 0.0046
278 PALPITATIONS 541 0.0046
279 PRODUCT DOSE OMISSION IN ERROR 130 0.0046
280 PRODUCT ADMINISTRATION INTERRUPTED 36 0.0046
281 HAEMATOCHEZIA 253 0.0046
282 DEEP VEIN THROMBOSIS 297 0.0046
283 GLUCOSE TOLERANCE IMPAIRED 27 0.0046
284 ANAL INCONTINENCE 41 0.0046
285 DIZZINESS POSTURAL 44 0.0045
286 DRY THROAT 46 0.0045
287 UPPER LIMB FRACTURE 90 0.0045
288 ECZEMA 235 0.0045
289 HIP FRACTURE 144 0.0045
290 CONFUSIONAL STATE 719 0.0044
291 RED BLOOD CELL COUNT DECREASED 127 0.0044
292 SPINAL OSTEOARTHRITIS 39 0.0044
293 SKIN DISCOLOURATION 203 0.0044
294 OSTEOPENIA 67 0.0044
295 FALL 1465 0.0044
296 ABNORMAL LOSS OF WEIGHT 30 0.0044
297 HEART RATE DECREASED 154 0.0044
298 NOCTURIA 53 0.0044
299 HAEMOGLOBIN DECREASED 448 0.0044
300 PRODUCT QUALITY ISSUE 592 0.0044
301 HAEMORRHAGE INTRACRANIAL 65 0.0043
302 PRODUCT PHYSICAL CONSISTENCY ISSUE 24 0.0043
303 DYSPHONIA 253 0.0043
304 GLOMERULAR FILTRATION RATE DECREASED 53 0.0043
305 BOWEL MOVEMENT IRREGULARITY 33 0.0043
306 DERMATITIS CONTACT 49 0.0043
307 TRANSFUSION 45 0.0043
308 BALANCE DISORDER 371 0.0043
309 BLOOD POTASSIUM DECREASED 129 0.0043
310 PRODUCT LEAKAGE 24 0.0043
311 PRODUCT SUBSTITUTION ISSUE 246 0.0043
312 BRADYCARDIA 226 0.0043
313 HALLUCINATION 320 0.0042
314 ATELECTASIS 41 0.0042
315 INCREASED TENDENCY TO BRUISE 39 0.0042
316 CARDIAC FAILURE CONGESTIVE 340 0.0042
317 HAEMORRHAGIC STROKE 33 0.0042
318 DEMENTIA 118 0.0042
319 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 219 0.0042
320 LYMPHOEDEMA 29 0.0042
321 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 37 0.0042
322 COLITIS ULCERATIVE 186 0.0042
323 SENSATION OF FOREIGN BODY 35 0.0041
324 POLYURIA 34 0.0041
325 RESPIRATORY TRACT INFECTION 108 0.0041
326 CHRONIC KIDNEY DISEASE 315 0.0041
327 SLEEP APNOEA SYNDROME 79 0.0041
328 RALES 24 0.0041
329 PRODUCTIVE COUGH 197 0.0041
330 FULL BLOOD COUNT DECREASED 83 0.0041
331 EAR PAIN 80 0.0041
332 DRY MOUTH 333 0.0041
333 BLOOD CHOLESTEROL INCREASED 191 0.0041
334 HYPERTENSION 864 0.0041
335 ARTERIOSCLEROSIS CORONARY ARTERY 27 0.0041
336 SKIN HYPERPIGMENTATION 35 0.0041
337 GAIT INABILITY 136 0.0041
338 BLOOD PRESSURE DIASTOLIC DECREASED 30 0.0041
339 ACUTE RESPIRATORY FAILURE 78 0.0041
340 ACUTE KIDNEY INJURY 620 0.0040
341 TASTE DISORDER 82 0.0040
342 INFUSION SITE ERYTHEMA 34 0.0040
343 FACIAL PAIN 36 0.0040
344 PHARYNGITIS 50 0.0040
345 MALIGNANT MELANOMA 54 0.0040
346 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 136 0.0040
347 HYPOMAGNESAEMIA 56 0.0040
348 C-REACTIVE PROTEIN INCREASED 146 0.0040
349 BLOOD CALCIUM DECREASED 45 0.0040
350 PELVIC FRACTURE 31 0.0040
351 PRODUCT LABEL ISSUE 27 0.0040
352 DUODENAL ULCER 28 0.0040
353 ELECTROLYTE IMBALANCE 46 0.0040
354 PURPURA 35 0.0040
355 HAEMORRHOIDS 77 0.0039
356 THROAT IRRITATION 177 0.0039
357 PULMONARY THROMBOSIS 43 0.0039
358 MICTURITION URGENCY 45 0.0039
359 RHINORRHOEA 254 0.0039
360 BASAL CELL CARCINOMA 61 0.0039
361 MYOSITIS 35 0.0039
362 SYNCOPE 390 0.0039
363 BLOOD COUNT ABNORMAL 59 0.0039
364 PRODUCT DISTRIBUTION ISSUE 36 0.0039
365 BURNING SENSATION 272 0.0039
366 WHEEZING 230 0.0039
367 MUSCLE ATROPHY 49 0.0039
368 MIDDLE INSOMNIA 72 0.0039
369 INTERNAL HAEMORRHAGE 44 0.0038
370 HOT FLUSH 290 0.0038
371 OESOPHAGITIS 42 0.0038
372 MUSCULOSKELETAL DISCOMFORT 66 0.0038
373 ULCER 61 0.0038
374 BLADDER DISORDER 38 0.0038
375 BLOOD UREA INCREASED 64 0.0038
376 EAR DISCOMFORT 39 0.0038
377 MITRAL VALVE INCOMPETENCE 43 0.0038
378 ORAL PAIN 85 0.0038
379 ACIDOSIS 29 0.0038
380 HYPOPHAGIA 97 0.0038
381 WALKING AID USER 25 0.0038
382 DIABETES MELLITUS 289 0.0038
383 HEAD DISCOMFORT 67 0.0038
384 BLOOD PRESSURE DECREASED 250 0.0038
385 PULMONARY MASS 56 0.0038
386 SPINAL COMPRESSION FRACTURE 31 0.0037
387 CEREBROVASCULAR ACCIDENT 633 0.0037
388 TOOTH INFECTION 49 0.0037
389 PEMPHIGOID 28 0.0037
390 PHARMACEUTICAL PRODUCT COMPLAINT 96 0.0037
391 HAIR COLOUR CHANGES 46 0.0037
392 ANGINA UNSTABLE 24 0.0037
393 POLLAKIURIA 154 0.0037
394 BLOOD PRESSURE INCREASED 561 0.0037
395 RASH PAPULAR 82 0.0037
396 TRICUSPID VALVE INCOMPETENCE 29 0.0036
397 GASTRITIS 96 0.0036
398 FAECES DISCOLOURED 79 0.0036
399 BLOOD POTASSIUM INCREASED 59 0.0036
400 BLOOD IRON DECREASED 43 0.0036
401 ATAXIA 43 0.0036
402 CONCUSSION 28 0.0036
403 IMPAIRED DRIVING ABILITY 41 0.0036
404 HYPOTHYROIDISM 115 0.0036
405 PULMONARY OEDEMA 161 0.0036
406 SCAB 41 0.0036
407 VITAMIN D DEFICIENCY 35 0.0036
408 WEIGHT DECREASED 1001 0.0036
409 OEDEMA PERIPHERAL 436 0.0036
410 URINARY TRACT INFECTION 609 0.0036
411 RENAL TUBULAR NECROSIS 35 0.0036
412 AGEUSIA 89 0.0036
413 WEIGHT FLUCTUATION 37 0.0035
414 PHOTOSENSITIVITY REACTION 58 0.0035
415 RENAL FAILURE ACUTE 149 0.0035
416 EYE MOVEMENT DISORDER 24 0.0035
417 EXOSTOSIS 32 0.0035
418 POST PROCEDURAL COMPLICATION 67 0.0035
419 SINUS CONGESTION 47 0.0035
420 BLOOD URINE PRESENT 66 0.0035
421 LOCALISED INFECTION 84 0.0035
422 ASTHENIA 1306 0.0035
423 COUGH 974 0.0035
424 VENTRICULAR EXTRASYSTOLES 36 0.0035
425 MUSCULAR WEAKNESS 393 0.0035
426 CONSTIPATION 754 0.0035
427 PLATELET COUNT INCREASED 45 0.0034
428 DECUBITUS ULCER 28 0.0034
429 FOOT DEFORMITY 38 0.0034
430 ANGINA PECTORIS 98 0.0034
431 AORTIC ANEURYSM 26 0.0034
432 MOUTH HAEMORRHAGE 25 0.0034
433 PULMONARY EMBOLISM 324 0.0034
434 JOINT DISLOCATION 36 0.0034
435 LUNG INFILTRATION 30 0.0034
436 SNEEZING 76 0.0034
437 CHOKING 66 0.0034
438 INTENTIONAL PRODUCT USE ISSUE 296 0.0034
439 TOOTH DISORDER 75 0.0034
440 BLOOD THYROID STIMULATING HORMONE INCREASED 31 0.0034
441 APHONIA 47 0.0034
442 PULMONARY HYPERTENSION 70 0.0034
443 HYPOKALAEMIA 155 0.0034
444 CARDIAC DISORDER 314 0.0034
445 COLON CANCER 50 0.0034
446 HEAD INJURY 106 0.0033
447 DIZZINESS 1663 0.0033
448 RENAL FAILURE 442 0.0033
449 WOUND 93 0.0033
450 URINARY RETENTION 111 0.0033
451 BACK DISORDER 54 0.0033
452 GASTROOESOPHAGEAL REFLUX DISEASE 267 0.0033
453 MULTIPLE ALLERGIES 26 0.0033
454 INITIAL INSOMNIA 34 0.0033
455 GENERALISED OEDEMA 41 0.0033
456 RIB FRACTURE 68 0.0033
457 NASAL CONGESTION 194 0.0033
458 MUSCULOSKELETAL CHEST PAIN 51 0.0033
459 POOR VENOUS ACCESS 34 0.0033
460 CORONARY ARTERY OCCLUSION 45 0.0033
461 ROTATOR CUFF SYNDROME 42 0.0033
462 ACCIDENT 39 0.0033
463 EPISTAXIS 244 0.0033
464 PAIN IN EXTREMITY 961 0.0033
465 ABDOMINAL DISCOMFORT 547 0.0033
466 INFUSION SITE PAIN 42 0.0033
467 MIGRAINE 311 0.0033
468 OSTEOPOROSIS 134 0.0033
469 HEMIPLEGIA 27 0.0032
470 FEELING COLD 90 0.0032
471 MYASTHENIA GRAVIS 26 0.0032
472 CONDITION AGGRAVATED 972 0.0032
473 ASTHMA 361 0.0032
474 PNEUMONIA 1026 0.0032
475 DRUG ADMINISTRATION ERROR 97 0.0032
476 GASTROINTESTINAL HAEMORRHAGE 264 0.0032
477 HAEMATEMESIS 80 0.0032
478 PERIPHERAL SWELLING 486 0.0032
479 GAIT DISTURBANCE 603 0.0031
480 PRURITUS GENERALISED 68 0.0031
481 WRONG DRUG ADMINISTERED 28 0.0031
482 RESTLESS LEGS SYNDROME 57 0.0031
483 NEUTROPHIL COUNT INCREASED 32 0.0031
484 PERSONALITY CHANGE 29 0.0031
485 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 32 0.0031
486 CLOSTRIDIUM DIFFICILE COLITIS 33 0.0031
487 SOMNOLENCE 626 0.0031
488 BACTERIAL INFECTION 58 0.0031
489 NEPHROPATHY 29 0.0031
490 TENDONITIS 48 0.0031
491 EATING DISORDER 66 0.0031
492 PRODUCT DOSE OMISSION 202 0.0031
493 ORAL DISCOMFORT 43 0.0031
494 DEHYDRATION 412 0.0031
495 HAEMATOMA 80 0.0031
496 WRIST FRACTURE 37 0.0031
497 BRONCHOSPASM 44 0.0031
498 NERVOUSNESS 161 0.0031
499 ADVERSE DRUG REACTION 276 0.0031
500 CARPAL TUNNEL SYNDROME 43 0.0031
501 SKIN CANCER 66 0.0031
502 LIP SWELLING 102 0.0031
503 BLISTER 172 0.0031
504 SKIN LESION 84 0.0031
505 FATIGUE 2383 0.0031
506 ELECTROCARDIOGRAM ABNORMAL 24 0.0031
507 PERIPHERAL COLDNESS 42 0.0031
508 CHEST DISCOMFORT 313 0.0031
509 PHARYNGEAL OEDEMA 47 0.0031
510 CYSTITIS 97 0.0030
511 URINARY INCONTINENCE 90 0.0030
512 SLEEP DISORDER 214 0.0030
513 NEPHROLITHIASIS 139 0.0030
514 BLOOD PRESSURE SYSTOLIC INCREASED 59 0.0030
515 PULMONARY FIBROSIS 58 0.0030
516 CARDIOMEGALY 37 0.0030
517 LIMB DISCOMFORT 93 0.0030
518 MUSCLE STRAIN 26 0.0030
519 JOINT INJURY 64 0.0030
520 ABASIA 74 0.0030
521 ANAEMIA 571 0.0030
522 HAIR TEXTURE ABNORMAL 40 0.0030
523 PRODUCT AVAILABILITY ISSUE 68 0.0030
524 UNRESPONSIVE TO STIMULI 77 0.0030
525 THROMBOSIS 240 0.0030
526 NEUROPATHY PERIPHERAL 283 0.0030
527 DYSPNOEA 1682 0.0030
528 DEPRESSION 676 0.0030
529 PETECHIAE 31 0.0030
530 BLOOD CALCIUM INCREASED 26 0.0030
531 SWELLING FACE 193 0.0030
532 MUSCLE DISORDER 24 0.0030
533 HEADACHE 1854 0.0030
534 SECRETION DISCHARGE 37 0.0030
535 FLUID RETENTION 150 0.0029
536 HERNIA 57 0.0029
537 SINUSITIS 302 0.0029
538 DYSSTASIA 86 0.0029
539 NECK PAIN 164 0.0029
540 DISORIENTATION 116 0.0029
541 CONTUSION 281 0.0029
542 ARTHROPATHY 162 0.0029
543 DYSKINESIA 118 0.0029
544 COVID-19 508 0.0029
545 EXPOSURE VIA SKIN CONTACT 75 0.0029
546 RASH MACULAR 101 0.0029
547 GAMMA-GLUTAMYLTRANSFERASE INCREASED 64 0.0029
548 CHEST PAIN 534 0.0029
549 FUNGAL INFECTION 96 0.0029
550 CELLULITIS 145 0.0029
551 RENAL DISORDER 134 0.0029
552 LACERATION 27 0.0029
553 ARTERIOSCLEROSIS 27 0.0029
554 DECREASED APPETITE 665 0.0029
555 PAIN IN JAW 81 0.0029
556 DYSURIA 105 0.0028
557 BACK INJURY 31 0.0028
558 OXYGEN SATURATION DECREASED 160 0.0028
559 SMALL INTESTINAL OBSTRUCTION 35 0.0028
560 INCONTINENCE 30 0.0028
561 DYSPEPSIA 278 0.0028
562 MELAENA 62 0.0028
563 MYALGIA 478 0.0028
564 CHOLELITHIASIS 92 0.0028
565 RASH PRURITIC 152 0.0028
566 OEDEMA 152 0.0028
567 DENTAL CARIES 31 0.0028
568 HYPERCHOLESTEROLAEMIA 27 0.0028
569 BACK PAIN 647 0.0028
570 BLOOD CREATININE INCREASED 181 0.0028
571 LYMPHOCYTE COUNT DECREASED 49 0.0028
572 EXPIRED PRODUCT ADMINISTERED 92 0.0028
573 SKIN FISSURES 54 0.0028
574 SQUAMOUS CELL CARCINOMA 26 0.0028
575 OSTEOMYELITIS 50 0.0028
576 HAEMOPTYSIS 77 0.0028
577 KIDNEY INFECTION 54 0.0027
578 MEMORY IMPAIRMENT 378 0.0027
579 SCRATCH 29 0.0027
580 HEPATOMEGALY 27 0.0027
581 PLASMA CELL MYELOMA 107 0.0027
582 APATHY 40 0.0027
583 LETHARGY 157 0.0027
584 TREMOR 452 0.0027
585 HYPOTENSION 545 0.0027
586 SKIN ULCER 70 0.0027
587 CIRCULATORY COLLAPSE 46 0.0027
588 THERAPY INTERRUPTED 193 0.0027
589 RASH ERYTHEMATOUS 129 0.0027
590 SPINAL FRACTURE 54 0.0027
591 ANOSMIA 39 0.0027
592 CEREBRAL HAEMORRHAGE 96 0.0027
593 HYPOGLYCAEMIA 130 0.0027
594 ACUTE MYOCARDIAL INFARCTION 79 0.0027
595 HYPERCALCAEMIA 33 0.0027
596 PRODUCT USE ISSUE 502 0.0027
597 CANDIDA INFECTION 45 0.0027
598 PRESCRIBED UNDERDOSE 53 0.0027
599 HYPERSOMNIA 76 0.0026
600 INSOMNIA 703 0.0026
601 BURSITIS 32 0.0026
602 GINGIVAL BLEEDING 36 0.0026
603 PRESYNCOPE 64 0.0026
604 MUSCULOSKELETAL DISORDER 50 0.0026
605 BREAST PAIN 28 0.0026
606 MUSCULOSKELETAL PAIN 137 0.0026
607 SPEECH DISORDER 137 0.0026
608 LUNG DISORDER 128 0.0026
609 SUPRAVENTRICULAR TACHYCARDIA 25 0.0026
610 INTERVERTEBRAL DISC PROTRUSION 57 0.0026
611 GASTROENTERITIS 38 0.0026
612 DIARRHOEA 1678 0.0026
613 HEMIPARESIS 44 0.0026
614 SKIN EXFOLIATION 219 0.0026
615 INTENTIONAL DOSE OMISSION 74 0.0026
616 PRODUCT STORAGE ERROR 227 0.0026
617 TENDON RUPTURE 32 0.0026
618 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 467 0.0026
619 TENDERNESS 27 0.0026
620 ERUCTATION 50 0.0026
621 FEMUR FRACTURE 80 0.0026
622 CARDIOGENIC SHOCK 37 0.0026
623 CARDIAC FAILURE 207 0.0026
624 BLOOD ALKALINE PHOSPHATASE INCREASED 64 0.0026
625 NIGHT SWEATS 83 0.0026
626 HEART RATE INCREASED 255 0.0026
627 PRURITUS 986 0.0026
628 PRODUCT DOSE OMISSION ISSUE 754 0.0026
629 MOBILITY DECREASED 184 0.0026
630 MYELODYSPLASTIC SYNDROME 37 0.0026
631 CONTRAINDICATED PRODUCT ADMINISTERED 77 0.0025
632 METABOLIC ACIDOSIS 81 0.0025
633 RETCHING 54 0.0025
634 FOOT FRACTURE 48 0.0025
635 MUSCLE TIGHTNESS 41 0.0025
636 RENAL INJURY 75 0.0025
637 DYSARTHRIA 95 0.0025
638 ISCHAEMIC STROKE 45 0.0025
639 COAGULOPATHY 42 0.0025
640 SKIN DISORDER 84 0.0025
641 THERAPY CESSATION 129 0.0025
642 MUSCLE SPASMS 461 0.0025
643 RESPIRATORY DISORDER 75 0.0025
644 DRUG INEFFECTIVE 3298 0.0025
645 INTESTINAL OBSTRUCTION 94 0.0025
646 THERAPY NON-RESPONDER 112 0.0025
647 LEUKOCYTOSIS 45 0.0025
648 FLATULENCE 141 0.0025
649 DIABETES MELLITUS INADEQUATE CONTROL 44 0.0025
650 DERMATITIS 52 0.0025
651 ERYTHEMA 510 0.0025
652 CHROMATURIA 56 0.0025
653 HYPOKINESIA 36 0.0025
654 HEPATIC ENZYME INCREASED 169 0.0025
655 WHITE BLOOD CELL COUNT INCREASED 95 0.0025
656 DIALYSIS 35 0.0025
657 INCORRECT DOSE ADMINISTERED 563 0.0025
658 DYSPHAGIA 234 0.0025
659 FEEDING DISORDER 50 0.0025
660 GALLBLADDER DISORDER 44 0.0025
661 NASOPHARYNGITIS 454 0.0025
662 MYOCARDIAL ISCHAEMIA 28 0.0025
663 RASH 1072 0.0025
664 WHITE BLOOD CELL COUNT DECREASED 265 0.0024
665 BACTERAEMIA 29 0.0024
666 DISCOMFORT 149 0.0024
667 PNEUMONIA ASPIRATION 61 0.0024
668 OROPHARYNGEAL PAIN 226 0.0024
669 LABORATORY TEST ABNORMAL 72 0.0024
670 PLATELET COUNT DECREASED 260 0.0024
671 SURGERY 143 0.0024
672 CARDIOMYOPATHY 36 0.0024
673 RESPIRATORY FAILURE 177 0.0024
674 GASTRIC ULCER 46 0.0024
675 CYST 30 0.0024
676 INABILITY TO AFFORD MEDICATION 24 0.0024
677 MYDRIASIS 31 0.0024
678 HYPERGLYCAEMIA 88 0.0024
679 HYPOXIA 85 0.0024
680 MALNUTRITION 27 0.0024
681 DECREASED ACTIVITY 26 0.0024
682 THIRST 43 0.0024
683 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 171 0.0024
684 PANCREATITIS ACUTE 54 0.0024
685 LOWER LIMB FRACTURE 46 0.0024
686 ADRENAL INSUFFICIENCY 29 0.0024
687 PRODUCT ODOUR ABNORMAL 25 0.0024
688 PLEURAL EFFUSION 145 0.0024
689 PERICARDIAL EFFUSION 55 0.0024
690 HYPOAESTHESIA 356 0.0024
691 MENTAL STATUS CHANGES 66 0.0024
692 ECONOMIC PROBLEM 36 0.0024
693 PARALYSIS 34 0.0024
694 ACTIVITIES OF DAILY LIVING IMPAIRED 47 0.0024
695 BLOOD BILIRUBIN INCREASED 64 0.0024
696 INFLAMMATION 122 0.0024
697 GASTROINTESTINAL PAIN 26 0.0024
698 MASS 33 0.0024
699 JOINT SWELLING 285 0.0024
700 ORAL HERPES 46 0.0024
701 INSURANCE ISSUE 36 0.0024
702 ABNORMAL DREAMS 65 0.0024
703 TACHYPNOEA 32 0.0024
704 NEURALGIA 57 0.0023
705 MALAISE 1025 0.0023
706 COMA 111 0.0023
707 TOOTH EXTRACTION 29 0.0023
708 SWELLING 218 0.0023
709 HAEMATURIA 79 0.0023
710 FIBROMYALGIA 56 0.0023
711 GLYCOSYLATED HAEMOGLOBIN INCREASED 58 0.0023
712 LOSS OF CONSCIOUSNESS 294 0.0023
713 BLOOD CREATINE PHOSPHOKINASE INCREASED 66 0.0023
714 EAR INFECTION 61 0.0023
715 CEREBRAL INFARCTION 56 0.0023
716 DRUG DISPENSING ERROR 35 0.0023
717 BONE PAIN 134 0.0023
718 APHASIA 69 0.0023
719 ARTHRALGIA 950 0.0023
720 ORAL CANDIDIASIS 30 0.0023
721 GLOSSODYNIA 51 0.0023
722 INFLUENZA 254 0.0023
723 SEPSIS 254 0.0023
724 SPINAL OPERATION 28 0.0023
725 FRACTURE 43 0.0023
726 INTENTIONAL PRODUCT MISUSE 198 0.0023
727 ANKLE FRACTURE 35 0.0023
728 OBESITY 36 0.0023
729 ERECTILE DYSFUNCTION 58 0.0023
730 PARAESTHESIA 355 0.0023
731 LUNG INFECTION 35 0.0023
732 UPPER RESPIRATORY TRACT INFECTION 104 0.0022
733 LIVER FUNCTION TEST ABNORMAL 65 0.0022
734 VASCULITIS 26 0.0022
735 POOR QUALITY SLEEP 48 0.0022
736 FEELING ABNORMAL 534 0.0022
737 SKIN HAEMORRHAGE 33 0.0022
738 STOMATITIS 135 0.0022
739 GENERAL PHYSICAL HEALTH DETERIORATION 256 0.0022
740 TOOTHACHE 40 0.0022
741 UNEVALUABLE EVENT 167 0.0022
742 CYTOPENIA 27 0.0022
743 AMNESIA 143 0.0022
744 SARS-COV-2 TEST POSITIVE 29 0.0022
745 TREATMENT NONCOMPLIANCE 120 0.0022
746 HAEMORRHAGE 229 0.0022
747 TACHYCARDIA 193 0.0022
748 PANIC ATTACK 79 0.0022
749 IMPAIRED HEALING 71 0.0022
750 PAIN 1327 0.0022
751 HIP ARTHROPLASTY 33 0.0022
752 RENAL IMPAIRMENT 181 0.0022
753 DRUG INTERACTION 341 0.0021
754 MUSCULOSKELETAL STIFFNESS 187 0.0021
755 MYOCARDIAL INFARCTION 372 0.0021
756 PRODUCT COMPLAINT 54 0.0021
757 FLUID OVERLOAD 31 0.0021
758 PRODUCT USE IN UNAPPROVED INDICATION 527 0.0021
759 LOCAL SWELLING 37 0.0021
760 THERAPEUTIC RESPONSE UNEXPECTED 94 0.0021
761 ABDOMINAL PAIN UPPER 431 0.0021
762 BONE DISORDER 38 0.0021
763 PYREXIA 721 0.0021
764 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 35 0.0021
765 DISEASE RECURRENCE 98 0.0021
766 VENTRICULAR TACHYCARDIA 34 0.0021
767 SENSORY DISTURBANCE 33 0.0021
768 DRUG TOXICITY 28 0.0021
769 MOVEMENT DISORDER 66 0.0021
770 ALOPECIA 403 0.0021
771 LYMPHOPENIA 29 0.0020
772 FEELING JITTERY 39 0.0020
773 FEAR 55 0.0020
774 VIRAL INFECTION 68 0.0020
775 GASTRIC DISORDER 70 0.0020
776 THINKING ABNORMAL 38 0.0020
777 BLOOD TRIGLYCERIDES INCREASED 36 0.0020
778 NAUSEA 1603 0.0020
779 EXTRA DOSE ADMINISTERED 82 0.0020
780 CHILLS 237 0.0020
781 PRODUCT DISPENSING ERROR 44 0.0020
782 HERPES ZOSTER 116 0.0020
783 QUALITY OF LIFE DECREASED 27 0.0020
784 HYPOCALCAEMIA 38 0.0020
785 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 406 0.0020
786 HYPERTHYROIDISM 29 0.0020
787 DISEASE PROGRESSION 237 0.0020
788 DEVICE USE ISSUE 35 0.0020
789 COGNITIVE DISORDER 93 0.0020
790 PRODUCT PHYSICAL ISSUE 40 0.0020
791 PRODUCT PRESCRIBING ISSUE 43 0.0020
792 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 140 0.0020
793 TYPE 2 DIABETES MELLITUS 66 0.0020
794 IRRITABLE BOWEL SYNDROME 42 0.0020
795 LIVER FUNCTION TEST INCREASED 42 0.0020
796 PNEUMOTHORAX 31 0.0020
797 ENCEPHALOPATHY 48 0.0020
798 DEATH 1680 0.0019
799 DEVICE RELATED INFECTION 30 0.0019
800 PROTEINURIA 37 0.0019
801 THERAPEUTIC PRODUCT EFFECT DECREASED 87 0.0019
802 BLOOD GLUCOSE INCREASED 363 0.0019
803 HYPERHIDROSIS 248 0.0019
804 ANXIETY 547 0.0019
805 DEVICE OCCLUSION 27 0.0019
806 PARANOIA 33 0.0019
807 DELIRIUM 66 0.0019
808 SINUS TACHYCARDIA 27 0.0019
809 VOMITING 892 0.0019
810 PANCYTOPENIA 106 0.0019
811 DRUG EFFECT DECREASED 102 0.0019
812 OFF LABEL USE 1652 0.0019
813 INCREASED APPETITE 36 0.0019
814 ASPARTATE AMINOTRANSFERASE INCREASED 100 0.0019
815 IMMUNODEFICIENCY 28 0.0019
816 PNEUMONITIS 51 0.0019
817 JOINT STIFFNESS 49 0.0019
818 ABNORMAL BEHAVIOUR 74 0.0019
819 ACUTE RESPIRATORY DISTRESS SYNDROME 33 0.0019
820 ANHEDONIA 49 0.0019
821 COORDINATION ABNORMAL 26 0.0019
822 FEELING HOT 114 0.0019
823 SKIN IRRITATION 85 0.0019
824 BLOOD TEST ABNORMAL 26 0.0018
825 BRAIN FOG 29 0.0018
826 RESPIRATORY DISTRESS 51 0.0018
827 COLITIS 70 0.0018
828 CLOSTRIDIUM DIFFICILE INFECTION 40 0.0018
829 WEIGHT INCREASED 410 0.0018
830 IMMUNE SYSTEM DISORDER 24 0.0018
831 ROAD TRAFFIC ACCIDENT 76 0.0018
832 RASH GENERALISED 47 0.0018
833 LYMPHOMA 28 0.0018
834 KNEE ARTHROPLASTY 38 0.0018
835 ACUTE MYELOID LEUKAEMIA 28 0.0018
836 DEPRESSED LEVEL OF CONSCIOUSNESS 71 0.0018
837 LACTIC ACIDOSIS 58 0.0018
838 DRUG EFFECT INCOMPLETE 65 0.0018
839 OSTEONECROSIS OF JAW 44 0.0018
840 ACCIDENTAL EXPOSURE TO PRODUCT 183 0.0018
841 ABDOMINAL PAIN 413 0.0018
842 IMPAIRED GASTRIC EMPTYING 24 0.0018
843 STAPHYLOCOCCAL INFECTION 58 0.0018
844 AGITATION 129 0.0018
845 SCAR 30 0.0018
846 DRUG DOSE OMISSION 289 0.0017
847 EJECTION FRACTION DECREASED 27 0.0017
848 HEPATIC STEATOSIS 32 0.0017
849 MOUTH ULCERATION 36 0.0017
850 DIABETIC KETOACIDOSIS 41 0.0017
851 METASTASES TO LIVER 30 0.0017
852 ABDOMINAL DISTENSION 178 0.0017
853 RHABDOMYOLYSIS 71 0.0017
854 DRY SKIN 227 0.0017
855 THROMBOCYTOPENIA 190 0.0017
856 HEPATOCELLULAR INJURY 24 0.0017
857 PALLOR 46 0.0017
858 ILLNESS 173 0.0017
859 NEOPLASM MALIGNANT 112 0.0017
860 ALANINE AMINOTRANSFERASE INCREASED 103 0.0017
861 RHEUMATOID ARTHRITIS 190 0.0017
862 NEOPLASM PROGRESSION 58 0.0017
863 FACE OEDEMA 28 0.0017
864 AGGRESSION 83 0.0017
865 CARDIOVASCULAR DISORDER 42 0.0017
866 FLUSHING 168 0.0017
867 MENTAL IMPAIRMENT 40 0.0016
868 CYTOKINE RELEASE SYNDROME 33 0.0016
869 LEUKOPENIA 82 0.0016
870 DEPRESSED MOOD 86 0.0016
871 MUSCLE TWITCHING 37 0.0016
872 BLOOD GLUCOSE DECREASED 77 0.0016
873 THROAT TIGHTNESS 43 0.0016
874 COLD SWEAT 28 0.0016
875 CARDIAC ARREST 131 0.0016
876 MANIA 26 0.0016
877 RASH MACULO-PAPULAR 35 0.0016
878 INTERSTITIAL LUNG DISEASE 76 0.0016
879 DRUG PRESCRIBING ERROR 30 0.0016
880 HOSPITALISATION 239 0.0016
881 PERICARDITIS 26 0.0015
882 ABDOMINAL PAIN LOWER 39 0.0015
883 EPILEPSY 47 0.0015
884 CYANOSIS 24 0.0015
885 METASTASES TO BONE 25 0.0015
886 BODY TEMPERATURE INCREASED 31 0.0015
887 ABSCESS 24 0.0015
888 GASTROINTESTINAL DISORDER 133 0.0015
889 INJURY 104 0.0015
890 MENTAL DISORDER 64 0.0015
891 PRODUCT PRESCRIBING ERROR 35 0.0015
892 LIVER DISORDER 65 0.0015
893 DISTURBANCE IN ATTENTION 79 0.0015
894 DEVICE DELIVERY SYSTEM ISSUE 40 0.0015
895 APPLICATION SITE PAIN 32 0.0015
896 DRUG LEVEL INCREASED 24 0.0014
897 JAUNDICE 39 0.0014
898 ELECTROCARDIOGRAM QT PROLONGED 52 0.0014
899 SEIZURE 166 0.0014
900 INFLUENZA LIKE ILLNESS 118 0.0014
901 URTICARIA 239 0.0014
902 NEUTROPENIA 193 0.0014
903 INFECTION 204 0.0014
904 INFUSION RELATED REACTION 93 0.0014
905 NEUTROPHIL COUNT DECREASED 57 0.0014
906 STEVENS-JOHNSON SYNDROME 31 0.0014
907 PANCREATITIS 72 0.0014
908 ANGIOEDEMA 60 0.0014
909 RESTLESSNESS 49 0.0013
910 ALTERED STATE OF CONSCIOUSNESS 29 0.0013
911 INCORRECT PRODUCT ADMINISTRATION DURATION 29 0.0013
912 LYMPHADENOPATHY 47 0.0013
913 FEBRILE NEUTROPENIA 88 0.0013
914 LOWER RESPIRATORY TRACT INFECTION 60 0.0013
915 DISABILITY 26 0.0013
916 NERVOUS SYSTEM DISORDER 41 0.0013
917 MULTIPLE SCLEROSIS 62 0.0013
918 INTENTIONAL DRUG MISUSE 27 0.0013
919 HEPATITIS 33 0.0013
920 ILL-DEFINED DISORDER 78 0.0013
921 UNDERDOSE 93 0.0013
922 THERAPEUTIC RESPONSE SHORTENED 42 0.0013
923 SEPTIC SHOCK 55 0.0013
924 PRESCRIBED OVERDOSE 24 0.0012
925 IRRITABILITY 73 0.0012
926 ANAPHYLACTIC REACTION 67 0.0012
927 ASCITES 35 0.0012
928 THERAPEUTIC RESPONSE DECREASED 72 0.0012
929 CARDIO-RESPIRATORY ARREST 49 0.0012
930 PROSTATE CANCER 93 0.0012
931 HEPATIC FUNCTION ABNORMAL 43 0.0012
932 SEDATION 30 0.0011
933 MALIGNANT NEOPLASM PROGRESSION 117 0.0011
934 ADVERSE EVENT 105 0.0011
935 PSORIATIC ARTHROPATHY 46 0.0011
936 PSYCHOTIC DISORDER 33 0.0011
937 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 26 0.0011
938 PSORIASIS 143 0.0011
939 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 60 0.0011
940 LUNG NEOPLASM MALIGNANT 44 0.0011
941 INJECTION SITE BRUISING 85 0.0011
942 MOOD ALTERED 29 0.0011
943 MULTIPLE ORGAN DYSFUNCTION SYNDROME 30 0.0011
944 DERMATITIS ATOPIC 55 0.0010
945 DEVICE ISSUE 93 0.0010
946 INCORRECT DRUG ADMINISTRATION DURATION 29 0.0010
947 NO ADVERSE EVENT 186 0.0010
948 CONVULSION 58 0.0010
949 PROCEDURAL PAIN 28 0.0010
950 SUICIDAL IDEATION 91 0.0010
951 WRONG TECHNIQUE IN DRUG USAGE PROCESS 36 0.0010
952 CRYING 36 0.0010
953 LIVER INJURY 24 0.0010
954 NEEDLE ISSUE 28 0.0010
955 TARDIVE DYSKINESIA 27 0.0010
956 MUCOSAL INFLAMMATION 25 0.0010
957 INCORRECT DOSE ADMINISTERED BY DEVICE 25 0.0010
958 EMOTIONAL DISORDER 29 0.0009
959 BONE DENSITY DECREASED 29 0.0009
960 DRUG-INDUCED LIVER INJURY 29 0.0009
961 APPLICATION SITE ERYTHEMA 24 0.0009
962 INJECTION SITE HAEMORRHAGE 73 0.0009
963 INJECTION SITE RASH 28 0.0009
964 HEPATIC FAILURE 27 0.0009
965 EMOTIONAL DISTRESS 108 0.0009
966 PAIN OF SKIN 24 0.0009
967 BREAST CANCER 82 0.0009
968 OSTEONECROSIS 28 0.0009
969 INJECTION SITE PAIN 255 0.0008
970 DEVICE DISLOCATION 36 0.0008
971 MOOD SWINGS 26 0.0008
972 DEVICE MALFUNCTION 56 0.0008
973 INJECTION SITE PRURITUS 53 0.0008
974 MULTIPLE SCLEROSIS RELAPSE 54 0.0008
975 SKIN BURNING SENSATION 56 0.0008
976 OVERDOSE 167 0.0008
977 ABORTION SPONTANEOUS 30 0.0007
978 INJECTION SITE ERYTHEMA 92 0.0007
979 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 32 0.0007
980 INJECTION SITE MASS 25 0.0007
981 ACNE 51 0.0007
982 INJECTION SITE REACTION 46 0.0007
983 SUICIDE ATTEMPT 40 0.0007
984 DEVICE BREAKAGE 26 0.0006
985 INJECTION SITE SWELLING 48 0.0006
986 VAGINAL HAEMORRHAGE 26 0.0006
987 TOXICITY TO VARIOUS AGENTS 92 0.0005
988 BLADDER CANCER 32 0.0005
989 DEVICE DIFFICULT TO USE 32 0.0005
990 DRUG DEPENDENCE 34 0.0002